Your trusted source for investing success

Tag: Goldman Sachs

Lithium in 2018

Your free report includes:

  • Expert commentary
  • Stocks to buy
  • Market forecasts
Give me my free report!  
Data Investment Facts

Data Investment Facts

The data market is vast and can be somewhat complicated. In that regard, here is a brief overview of data investment facts for those looking to jump into the sector.

Amicus Therapeutics Announces Public Offering of Common Stock

Amicus Therapeutics (Nasdaq:FOLD) announced it has commenced a $250 million underwritten public offering of its common stock. J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC are acting as joint lead book-running managers, Cowen and Leerink Partners LLC are acting as co-book-running managers, and BofA Merrill Lynch is acting

Five Prime Therapeutics Announces Closing of Upsized Public Offering

Five Prime Therapeutics (Nasdaq:FPRX) announced today the closing of its upsized public offering of 5,897,435 shares of its common stock, which includes 769,230 shares sold upon the underwriters’ full exercise of their option to purchase additional shares, resulting in aggregate gross proceeds of $115 million, before deducting underwriting discounts and

Ultragenyx Announces Proposed Public Offering of Common Stock

Ultragenyx Pharmaceutical (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that it has commenced an underwritten public offering of up to $175,000,000 of shares of its common stock.

As quoted in the press release:
 In addition, the company is expected to grant

BeiGene Announces Closing of $800 Million Public Offering

BeiGene (NASDAQ:BGNE) a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced the closing of its follow-on public offering of 7,920,800 American Depositary Shares each representing 13 of its ordinary shares, par value $0.0001 per share, at a

Biotech Stocks in 2018

Find out how the market will look this year

Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
New Wastewater Filtration Technology Provides a New Lithium Source